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The  purposes  of  this  review  were  to:  1) determine  the  attrition  rates  for  exposure  with  response  preven-
tion  (ERP)  for  obsessive-compulsive  disorder  (OCD),  2) compare  them  to those  in other  treatments  for
OCD, and  3)  identify  predictors  of  ERP  attrition.  A systematic  literature  search  of randomized  controlled
trials  for ERP  for  OCD  yielded  21  studies,  representing  1400  participants.  Attrition  data  were  extracted
for  individual  treatment  conditions.  The  weighted  mean  dropout  rate for  ERP  was  14.7% (95% CI  [11.4%,
18.4%]).  This  figure  was  not  statistically  different  from  that  of comparison  conditions  (e.g.,  cognitive  ther-ropout
xposure with response prevention
bsessive-compulsive disorder
eta-analysis
apy;  OR  = 0.67–2.22,  all ps  >  0.15).  Only  two  studies  reported  refusal  rates  for  ERP  (weighted  mean  =  4.0%;
95%  CI  [0.7%,  9.2%]),  which  precluded  calculation  of  a  reliable  refusal  rate  for ERP.  Based  on  these  figures,
we  estimated  an  overall  attrition  rate  of 18.7%  for ERP.  Treatment  experience,  therapist  qualification,  and
number  of treatment  sessions  did  not  significantly  predict  dropout  rate.  Our  review  indicates  that  ERP
may have  treatment  dropout  rates  similar  to other  treatments  for  OCD.
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Obsessive-compulsive disorder (OCD) was once considered
hallenging to treat. Fortunately, exposure with response pre-
ention (ERP), cognitive-behavioral therapy (CBT) more broadly,
for OCD. ERP—the gold standard treatment—consists of gradual
exposure to anxiety-inducing obsessions and prevention or restric-
tion of engagement in anxiety-reducing rituals (Olatunji, Davisnti-depressants, and a combination of the two have been found to
e effective in treating this disorder (O’Connor et al., 2005). To date,
RP and CBT are the most supported psychotherapy treatments
∗ Corresponding author at: Utah State University, Department of Psychology, 2810
ld Main Hill, Logan, UT 84322-2810, United States.
E-mail address: michael.twohig@usu.edu (M.P. Twohig).
ttp://dx.doi.org/10.1016/j.janxdis.2016.03.006
887-6185/© 2016 Elsevier Ltd. All rights reserved.et al., 2013). Meta-analyses have found similarly large effect sizes
when comparing ERP, cognitive restructuring (CR), and ERP plus
CR (Abramowitz, Franklin & Foa, 2002; Rosa-Alcázar, Sánchez-
Meca, Gómez-Conesa, & Marín-Martínez, 2008). Olatunji, Davis
et al. (2013) recently conducted a meta-analysis of 16 randomized
controlled trials that included participants with a DSM-IV or DSM-
IV-TR diagnosis of OCD, a control group, and more than one single
session of CBT. Results showed that ERP (also called CBT) had larger
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ffect sizes on primary outcome measures compared to control con-
itions. In addition, some evidence suggests that ERP may  be more
ffective than cognitive therapy in the treatment of OCD (Olatunji,
osenfield et al., 2013).
Despite research supporting the efficacy of exposure therapy,
ervasive negative beliefs about exposure exist for therapists and
lients alike (e.g., Olatunji, Deacon, & Abramowitz, 2009; Zoellner
t al., 2011). Specifically, research has shown that therapists believe
hat the clients’ anxiety symptoms will increase with exposure
Cook, Schnurr, & Foa, 2004) and that clients will drop out or decom-
ensate during difficult exposure tasks (Deacon, Lickel, Farrell,
emp, & Hipol, 2013). Negative beliefs about exposure appear to
mpede the dissemination of exposure-based CBT. A recent sur-
ey conducted on therapists in a community setting revealed that
ractitioners use several CBT techniques with anxious clients but
ery few utilize exposure techniques (Hipol & Deacon, 2013). These
ndings are consistent with an early survey study showing that
xposure was under-utilized and often used in conjunction with
nxiety reduction techniques (Freiheit, Vye, Swan & Cady, 2004).
verall, it appears that the practice and dissemination of expo-
ure therapy are challenged by therapists’ negative beliefs about
he treatment. One of these beliefs is that ERP suffers from notable
ttrition (refusal prior to the start of treatment or dropout follow-
ng the start of treatment) rates. In other words, therapists may  be
rematurely discouraged by potential attrition and elect not to uti-
ize ERP. As a result, patients with OCD may  not be presented with
he best available treatment options, which has serious implica-
ions for treatment outcomes. Thus, a key question for addressing
herapist barriers to using ERP is whether treatment attrition rates
eally are especially high for ERP, as well as how ERP attrition rates
ompare to those observed in other interventions for OCD, such as
ognitive therapy.
At first glance, the dropout and refusal rates for ERP cited in stud-
es are not reassuring, which would be consistent with common
herapist concerns. One study estimated that 25% refuse to start
ehavioral therapy for OCD and nearly 20% more drop out prema-
urely after starting treatment (Schruers, Koning, Haack, Luermans
 Griez, 2005). Another study estimated that 25% of participants
efuse treatment due to beliefs about the difficulty of ERP (Franklin
 Foa, 2007), whereas Abramowitz, Taylor, and McKay (2009) cited
 25% dropout rate for ERP in their review on OCD. These arti-
les described attrition rates for ERP broadly, but most of them
ased their estimates on only one or two studies, which is not suf-
cient to make such generalizations. Furthermore, the rates were
ot determined or reported systematically, and operationalizations
f attrition might have varied across studies, making it difficult
o synthesize or compare rates as they have been presented. For
xample, Schruers et al. (2005) distinguished between dropout
nd refusal, whereas Franklin, Abramowitz, Kozak, Levitt, and Foa
2000) used attrition and dropout synonymously. Inconsistency in
eported data on treatment attrition rates for OCD treatment trials
as led researchers to suggest that the rates provided in the current
iterature are speculative and inconclusive (Santana, Fontenelle,
ücel & Fontenelle, 2013).
To our knowledge, no systematic analysis of attrition rates of
RP for OCD has been conducted. Empirically derived estimates
f weighted mean dropout and refusal rates for ERP across treat-
ent studies would give researchers and clinicians a better sense
f the acceptability of ERP to patients with OCD. Given the num-
er of published RCTs comparing ERP to other treatments for OCD,
here is now the opportunity for such a review to compare the rates
f dropout between ERP and other approaches to see if they are
specially elevated with ERP. This information can then be used to
nform therapist beliefs about ERP, and ultimately, its dissemina-
ion. Disorders 40 (2016) 8–17 9
The purpose of this study was  to conduct a meta-analysis of the
existing research on attrition (treatment dropout and refusal) rates
in randomized controlled trials (RCTs) of ERP for OCD. Results of
this evaluation will help the field determine if we have sufficient
data to report on attrition rates, and if we do, how they compare to
other treatment conditions.
1. Method
1.1. Literature search
A systematic search of the literature was conducted on PsycINFO
and PubMed, using the key words exposure and response preven-
tion and obsessive-compulsive disorder. Further manual searches
were conducted by examining the references of all available meta-
analyses and reviews. This process continued until no new relevant
articles were found.
To be included in the meta-analysis, studies needed to: (a) ran-
domly assign participants to treatment conditions; (b) contain at
least one ERP alone treatment condition; (c) use a face-to-face indi-
vidual psychotherapy format; (c) include participants who received
diagnoses of OCD based on clinical assessment; (d) use an adult
sample; and (e) be available in English. The search for relevant stud-
ies was  restricted to RCTs to facilitate the comparison of attrition
rates across conditions. Studies that (a) involved residential treat-
ment; or (b) did not provide sufficient information on dropout and
refusal rate for individual treatment conditions (i.e., only provided
study-level data) were excluded from the current meta-analysis.
Of the 579 articles found in the database searches, 28 studies pub-
lished between 1980 and 2015 met  initial inclusion criteria. For
articles that did not include information on dropout or refusal
rates by treatment condition, study authors were contacted with
requests for the relevant data. Five studies were subsequently
excluded because they failed to report enough information to calcu-
late either a dropout or refusal rate for individual conditions in the
original article, and authors either were unable to provide the data
(e.g., because data had been destroyed due to the age of the study)
or did not respond to our request for data. One study was  excluded
because it contained an inpatient phase of treatment. Another study
was excluded because it reanalyzed data from an already included
study. This resulted in a total of 21 studies for final analyses.
1.2. Data abstraction
To analyze participant flow of ERP compared to other
treatments, data from each condition of the RCTs were
collected separately and assigned to one of the following
groups: ERP, ERP + other psychotherapies (e.g., motivational inter-
viewing), ERP + technology (e.g., telephone-administered ERP),
ERP + medications, cognitive therapy (CT), CT + medications, behav-
ior therapy (BT), CBT, CBT + medications, medications only, active
control (e.g., stress management), inactive control (e.g., waitlist),
and group interventions (e.g., group format CBT). In the present
study, ERP or standard ERP was  defined as individual face-to-face
ERP.
Among the 21 studies, a wide variety of time points (e.g.,
“participants that were randomized,” “participants that started
treatment,” and “participants that completed baseline”) related to
participant recruitment, allocation, and attrition were reported.
There was  an overall lack of standardization in the methods of
reporting participant flow. Therefore, the exact rates reported in
the original studies or rates calculated from clearly defined data
were extracted to determine dropout and refusal rates. For one of
the studies, refusal rate was obtained from a subsequent article
(Olatunji, Rosenfield et al., 2013) that reanalyzed the original data.
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e  defined dropout as attrition following the start of treatment;
ttrition prior to the start of treatment was considered refusal.
ropout and refusal data were determined for each individual
ondition based on these operationalizations. The second author
nitially scored all studies. The third and fifth authors each inde-
endently rescored all studies and any discrepancies were clarified
mong the authors.
.3. Analyses
The purposes of this study were to determine the attrition rates
i.e., treatment dropout and refusal) of ERP for OCD in RCTs, to com-
are attrition rates across treatment conditions, and to identify
ignificant predictors of attrition rate in ERP. Because this study
ocused on attrition in ERP exclusively and not the treatment of
CD generally, only studies that reported data on an ERP alone
ondition were included. The main outcome variable was per-
entage of dropout; we were unable to calculate a reliable overall
efusal rate due to insufficient data. In line with recommendations
or conducting meta-analyses of proportion data, we  transformed
he data using the Freeman-Tukey double arcsine transformation
Barendregt, Doi, Lee, Norman, & Vos, 2013; Freeman & Tukey,
950). The double arcsine transformation is recommended over the
ogit transformation (another way to transform proportion data)
ecause it more effectively addresses variance instability for esti-
ates close to 0 or 1 (Barendregt et al., 2013). In addition, due to
nticipated heterogeneity across studies, random-effects models
ere used to estimate dropout and refusal rates. Heterogeneity
as assessed with the Cochran’s Q test and the I2 test statistic
Hedges & Olkin, 1985; Higgins, Thompson, Deeks, & Altman, 2003).
eparate analyses were conducted for continuous and categorical
redictors of interest. A meta-regression was used to evaluate the
ontinuous predictor of dropout, whereas random effects models
ith Q-tests based on analysis of variance were used to compare
ifferences in dropout rate across levels of the categorical predic-
ors (Borenstein, Hedges, Higgins, & Rothstein, 2009). All analyses
ere performed using the metafor package in R and Comprehensive
eta-analysis, a statistical program designed for meta-analyses
Borenstein, Hedges, Higgins, & Rothstein, 2005; R Core Team,
015; Viechtbauer, 2010).
Initial descriptive analyses examined the types of compari-
on treatment conditions included in the studies, the rate with
hich studies reported dropout and refusal rates, as well as
he reported reason for dropout. Primary analyses calculated
he inverse variance-weighted rates and confidence intervals for
reatment dropout by treatment condition, as well as compared
ropout rates between ERP and other conditions using odds
atios. Of note, weighted estimates were close to the mean and
edian values for treatment dropout and refusal for all included
tudies.
Based on Borenstein et al.’s (2009) sample size recommendation
f 10 studies to one covariate for meta-regression, we determined
hat our analyses were sufficiently powered to detect a predictor
ffect if it existed. Potential predictors of dropout were discussed
mong the authors, and only relevant variables for which suf-
cient data were provided were included in the analyses. They
ncluded: treatment delivery experience for the therapist, thera-
ist qualification, and number of treatment sessions. The first two
ariables were coded independently by the first and fourth authors,
nd discrepancies were resolved through discussion. Treatment
xperience was categorized as (a) no professional experience (e.g.,
raduate students), (b) professional experience not specific to CBT,
r (c) professional experience with or expertise in CBT. Thera-
ist qualification was classified as (a) student, (b) non-psychologist
rofessional or therapist, or (c) doctoral-level therapist or psychol-
gist. The authors coded these qualitative variables conservatively, Disorders 40 (2016) 8–17
assigning higher codes (e.g., expertise in CBT) only when there
was sufficient information to indicate so. The number of ther-
apy sessions was determined by the figure indicated in the
study treatment protocol; if the number of sessions varied across
participants, the mean (as reported by the study authors) was
used.
2. Results
2.1. Descriptive information
A total of 21 studies that had ERP alone as a treatment con-
dition were included in the analyses, with publication years
between 1991 and 2014. These studies represented a total of
1400 participants. There were 10 comparison conditions utilized
in these studies (conditions are followed by their number of times
represented): ERP + other psychotherapies = 1 (motivational inter-
viewing); ERP + technology = 2 (self-administered bibliotherapy,
telephone-administered); ERP + medication = 4 (clomipramine, flu-
voxamine); CT = 7; CT + medication = 1 (fluvoxamine); BT = 1 (sati-
ation therapy); CBT = 2; active control = 2 (stress management,
progressive muscle relaxation); inactive control = 2 (waitlist); and
group interventions = 3 (group CBT, group ERP). The majority of the
studies compared two conditions (k = 17), three compared three,
and one compared five. Characteristics of included studies are sum-
marized in Table 1.
All 21 studies provided data for dropout rates by treatment con-
dition. Of the 21 studies included in the final analysis, only 7 offered
data on reasons for dropout. These data on reasons for dropout are
limited because only four provide these data for each treatment
condition; the remaining are presented across all conditions at the
study level. In terms of refusal rates, only 11 of 21 (52.4%) pro-
vided sufficient data to calculate a treatment refusal rate based on
the definition used in this review (attrition prior to starting treat-
ment). However, our review indicated that calculating an overall
refusal rate for ERP would be difficult, as only 2 of the 11 stud-
ies that reported refusal rate did so for each individual treatment
condition (or 9.5% of the total sample). Instead, most studies only
provided data on treatment refusal at the study level.
2.2. Dropout rates
The number of conditions as well as the dropout mean and
range for each treatment type are depicted graphically in Fig. 1.
The weighted mean dropout rate for ERP was  14.7% (95% CI [11.4%,
18.4%]). Table 2 provides a summary of refusal and dropout rates
for both ERP only and study-level data, along with model statistics.
2.3. Refusal rates
Only two studies reported refusal rates (after condition
assignment) for ERP, rendering a meta-analysis with those data
untenable. However, the specific refusal rates for ERP from both
studies were 4.8% and 3.6%, which yielded a weighted mean of 4.0%
(95% CI [0.7%, 9.2%]). These two studies included comparison condi-
tions: a CBT condition reported a refusal rate of 7.3%, and an active
control condition reported a refusal rate of 1.8%. These data are
limited in determining actual refusal rates for ERP and how they
compare to other treatments. However, 11 studies offered refusal
rates at the study level. The average refusal rate across studies was
12.0% (95% CI [3.4%, 24.3%]), and rates ranged from 0 to 76.6%. These
data are likely to be more useful in gauging refusal rates for psy-
chotherapy randomized controlled trials for OCD, as they are not
specific to ERP.
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Table  1
Study characteristics.
Author(s) and Year Sample
Size
Study
Therapist(s)
Therapist Train-
ing/Experience
Supervision ERP Description Session
Number
Frequency Exposure
Homework
Emmelkamp &
Beens (1991)
21 Clinical
psychology
students
Extensive course in
behavior therapy,
training in CBT
with OCD patients
Twice-weekly
group sessions,
supervised by
senior author
Self-controlled
exposure in vivo
and self-imposed
response
prevention
(Emmelkamp,
1982)
6 1–2 times
weekly
Yes
Fals-Stewart,
Marks, & Schafer
(1993)
93 Psychiatric
social workers
At least 1 year of
experience
conducting
behavior therapy
interventions for
OCD
Not described In vivo exposure
and/or imaginal
flooding with
response
prevention
24 Twice weekly Yes
van Oppen et al.
(1995)
71 Clinical
psychologists
Versed in behavior
therapy,
experience with
behavioral
treatment of OCD,
training in CT for
OCD
Weekly group
sessions during
which partial
audiotaped
recordings of
therapy sessions
were overheard
Self-controlled
exposure in vivo
and self-imposed
response
prevention
(Emmelkamp,
1982)
16 Once weekly Yes
van Balkom et al.
(1998)
117 Psychologists Experience with
behavioral
treatment for OCD,
training in CT
Not described Gradual
self-controlled
exposure in vivo
with gradual
self-imposed
response
prevention
(Hoogduin and
Hoogduin, 1984)
18 1–2 times
weekly
Yes
Kozak, Liebowitz, &
Foa (2000)
97 Cognitive
behavioral
therapists
Training in the
treatment protocol,
observed experts
conducting
treatment,
performed a
supervised
intensive CBT with
at  least one patient
Continuing
supervision with a
licensed
psychologist,
sessions were
videotaped and
discussed with
therapists several
times a week,
periodical therapist
meetings for
supervised review
of tapes and
therapy procedures
Graded in vivo and
imaginal exposure
with response
prevention
17 Every weekday
for 3 weeks,
then 2
consecutive
days in the
fourth week
Yes
Cottraux et al.
(2001)
65 Psychologists CBT diploma,
additional 20 h of
training
Supervision in the
case of significant
clinical problems
Therapist-aided
in vivo and
imaginal exposure
with response
prevention (Foa
and Wilson, 1991;
Marks, 1987)
14 Twice weekly
for 4 weeks,
then once
biweekly for 12
weeks
Yes
Abramowitz, Foa, &
Franklin (2003)
40 Doctoral-level
therapists
Training involved
didactics,
observing
treatment as a
cotherapist, and
conducting
individual therapy
under close
supervision by an
ERP expert; 1–16
years of experience
with ERP
Weekly group
supervision
meetings,
nonlicensed
therapists received
additional
individual
supervision on a
weekly basis
Therapist-
supervised in vivo
and imaginal
exposure with
ritual prevention,
and
self-monitoring
(Kozak and Foa,
1997)
15 (a) Every
weekday over
3  weeks (b)
Twice weekly
over 8 weeks
Yes
Krochmalik et al.
(2004)
22 Psychologists Not described Not described Graded exposure to
internal and
external OC
triggers with
response
prevention
(Andrews, Crino,
Hunt, Lampe, &
Page, 1994)
12 Once weekly Yes
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Table  1 (Continued)
Author(s) and Year Sample
Size
Study
Therapist(s)
Therapist Train-
ing/Experience
Supervision ERP Description Session
Number
Frequency Exposure
Homework
Foa et al. (2005) 149 ERP therapists Training included
observing experts
who conducted
ERP and
completing at least
one training case of
ERP
Ongoing weekly
supervision
In vivo and
imaginal exposure
with ritual
prevention,
discussion of
OCD-related beliefs
and
disconfirmatory
evidence provided
by exposure
exercises (Kozak
and Foa, 1997)
23 Every weekday
for 3 weeks,
then once
weekly for 8
weeks
Yes
O’Connor et al.
(2005)
44 Therapists Skilled in either 1
or a combination of
the study
treatments
Not described Supervised and
self-controlled
in vivo exposure
with response
prevention,
obsessional beliefs
were not addressed
(Steketee, 1993,
1999)
20 Once weekly Not
described
Whittal,
Thordarson, &
McLean (2005)
83 Licensed
clinical
psychologists,
psychology
interns
Experience with
treating OCD
(psychologists)
Supervision of
interns via
audiotape review
or cotherapy
In-session
graduated
exposure and
response
prevention,
cognitive elements
were not addressed
(McLean et al.,
2001; Van Noppen,
Steketee, McCorkle,
& Pato, 1997)
12 Once weekly Yes
Lovell et al. (2006) 86 Cognitive
behavioral
therapists
Trained and
experienced,
training days every
four months during
the first year of the
study
Fortnightly
supervision
Graded exposure
and response
prevention
10 Once weekly Yes
Anderson & Rees
(2007)
63 Postgraduate-
level clinical
psychology
students
Trained Treatment sessions
were videotaped
and reviewed in
regular supervision
with a clinical
psychologist
experienced in the
treatment of OCD
Cognitive
restructuring
integrated into
exposure exercises
(Rees and Nathan,
2001)
10 Once weekly Yes
Rowa et al. (2007) 28 Therapists At least one year of
experience treating
OCD with ERP
Regular
supervision
meetings with
senior therapists
Exposure and
response
prevention adapted
from ERP
treatment
protocols (e.g., Foa
and Franklin, 2001;
Steketee, 1993)
14 Once weekly
for the first and
last two
sessions, twice
weekly for all
other sessions
Yes
Tolin et al. (2007) 41 Doctoral-level
psychologist or
postdoctoral
fellow
Experienced Not described Gradual in vivo and
imaginal exposure
with response
prevention (Foa,
Steketee, Grayson,
Turner, & Latimer,
1984)
15 Twice weekly Not
described
Simpson et al.
(2008)
134 Psychologists Training included
manual review and
completion of at
least one training
case of each type
under supervision
Weekly group
supervision
included review of
audio or video
recordings
In vivo and
imaginal exposures
with response
prevention, formal
cognitive
techniques were
not used (Kozak
and Foa, 1997)
17 Twice weekly Yes
Wilhelm et al.
(2008)
23 Therapists Not described Supervision by
clinicians
specializing in OCD
Exposure and
response
prevention, formal
cognitive
restructuring was
not part of the
protocol (Kozak
and Foa, 1997)
10 Twice weekly Yes
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Table  1 (Continued)
Author(s) and Year Sample
Size
Study
Therapist(s)
Therapist Train-
ing/Experience
Supervision ERP Description Session
Number
Frequency Exposure
Homework
Khodarahimi
(2009)
60 Clinical
psychologist
Not described Not described In vivo and
imaginal exposure
with response
prevention
(Salkovskis and
Kirk, 1989)
12 Twice weekly Yes
Solem, Håland,
Vogel, Hansen, &
Wells (2009)
83 Graduate
psychology
students,
psychologists
Not described Not described for
individual
treatment
therapists
Exposure and
response
prevention, the
majority of therapy
sessions did not
use cognitive
techniques (Kozak
and Foa, 1997)
15.88
(mean)
Twice weekly Not
described
Simpson et al.
(2010)
30 Doctoral-level
therapists
Expertise in ERP,
served as ERP
therapists on other
NIMH-funded
clinical trials
Weekly group ERP
phone supervision
In vivo and
imaginal exposures
with response
prevention (Kozak
and Foa, 1997)
18 Twice weekly Yes
Vaccaro, Jones,
Menzies, &
Wootton (2013)
50 Clinical
psychologist
Experience with
treating patients
with OCD using the
ERP study protocol
Ongoing
supervision
provided as
required, weekly
meetings
In vivo exposure
and response
prevention,
cognitive
components were
not addressed
(Andrews, Crino,
Lampe, Hunt, &
Page, 2002)
14 Once weekly Yes
Note: ERP = exposure with response prevention; CBT = cognitive behavioral therapy; OCD = obsessive-compulsive disorder; CT = cognitive therapy; NIMH = National Institute
of  Mental Health.
Table 2
Dropout and refusal rates for ERP and study-level data.
Condition (k) Rate (%) 95% CI (%) I2 Q p
Dropout
ERP (21) 14.7 11.4, 18.4 20.77 24.44 0.22
Study-level (21) 15.0 11.1, 19.4 75.96 91.06 <0.001
Refusal
ERP  (2) 4.0 0.7, 9.2 0.00 0.10 0.75
Study-level (11) 12.0 3.4, 24.3 96.42 697.04 <0.001
Attritiona
ERP 18.7
Study level 27.0
N
2
e
9
c
d
E
d
F
o
i
a
2
c
(
d
Table 3
Dropout rates of ERP vs. other conditions.
Comparison condition (k) OR 95% CI p
Othera (23) 1.04 0.73, 1.49 0.83
Non-ERP (15) 1.27 0.82, 1.97 0.29
CTb (7) 1.06 0.58, 1.94 0.84
CT/CBTb (9) 1.26 0.78, 2.04 0.34
Other ERPc (8) 0.67 0.38, 1.18 0.17
Controld (3) 1.04 0.40, 2.67 0.94
Groupe (3) 2.22 0.71, 6.96 0.17
Note: ERP = exposure with response prevention; OR = odds ratio; CI = confidence
intervals; CT = cognitive therapy; CBT = cognitive behavioral therapy. The
Khodarahimi (2009) study was not included in these comparison analyses
due to zero dropout across all conditions.
a Included ERP conditions that incorporated technology, medication, or other
psychotherapies (motivational interviewing).
b Did not include psychotherapy plus medication conditions.
c These ERP conditions incorporated technology, medication, or other psy-
chotherapies (motivational interviewing).
dote: CI = confidence interval; ERP = exposure with response prevention.
a Calculated by adding up weighted average dropout and refusal rates.
.4. Comparison across conditions
Comparison analyses for dropout rates revealed no differ-
nce between standard ERP and all other conditions (OR = 1.04,
5% CI [0.73, 1.49], p = 0.83). When ERP dropout rates were
ompared to those of other non-ERP conditions (i.e., other con-
itions excluding ERP + other psychotherapies, ERP + technology,
RP + medication, and group ERP), there were still no significant
ifferences (OR = 1.27, 95% CI [0.82, 1.97], p = 0.29). Table 3 and
ig. 2 provide an overview of the dropout rates of ERP relative to
ther treatment conditions. The limited number of studies report-
ng refusal rates for ERP precluded a comparison of refusal rates
cross conditions.
.5. Predictors of dropoutTreatment experience (Q[2] = 0.23, p = 0.89), therapist qualifi-
ation (Q[2] = 0.49, p = 0.78), and number of treatment sessions
estimate = −0.02, Z = −0.61, p = 0.54) did not significantly predict
ropout rate in ERP.Included active control (stress management, progressive relaxation) and waitlist
conditions.
e Included group CBT and group ERP conditions.
2.6. Publication bias
A funnel plot was  used to evaluate publication bias. The slight
asymmetry of the funnel plot indicated possible publication bias
in the direction of excluding studies with higher ERP dropout rates
(see Fig. 3). However, the trim and fill method yielded a robust effect
size estimate.
3. DiscussionThe initial goal of this review was  to determine the attrition
rate of ERP based on the literature to date, and to compare that rate
to attrition rates in other treatment modalities. For the purpose
of this paper, attrition was  defined as the combination of those
14 C.W. Ong et al. / Journal of Anxiety Disorders 40 (2016) 8–17
Fig. 1. Dropout rates by treatment modality. Note: ERP = exposure with response prevention; CT = cognitive therapy; BT = behavior therapy; CBT = cognitive behavioral therapy.
F tios in
c
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t
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t
sig. 2. Forest plot for dropout rates of ERP vs. other conditions. Note: Higher odds ra
ondition.
ho refused treatment and those who dropped out of treatment.
ecause of the limited data on refusal rates, we could not determine
he attrition rate of ERP. Only 52.4% of included studies reported
ny refusal rate, with 9.5% reporting refusal rates for individual
reatment conditions. Analyzing the available data from 2 out of 21
tudies yielded a 4.0% refusal rate for ERP (95% CI [0.7%, 9.2%]). Moredicate greater likelihood of dropout in the ERP condition relative to the comparison
commonly, refusal rate was  reported at the study level (i.e., col-
lapsed across conditions), resulting in a 12.0% overall refusal rate.
In contrast, more consistent reporting of dropout data allowed us
to calculate a more robust estimate of dropout rate in ERP.
The weighted mean dropout rate for ERP of 14.7% was  lower
than rates reported in previous studies; rates closer to 25% have
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een commonly suggested (Abramowitz et al., 2009; Schruers et al.,
005). It is worth noting that unlike previous estimates, the average
ropout rate presented here was based on a standardized definition
f dropout and systematically aggregated data across 21 studies,
llowing us to have more confidence in its accuracy. There were
o statistically significant differences in dropout rate between ERP
nd other treatment conditions. In addition, the rates in ERP for
CD are comparable to what has been reported for other emo-
ional disorders. For example, similar dropout rates were found for
atients receiving treatment for PTSD (18.3%; Imel, Laska, Jakupcak,
 Simpson, 2013) as well as patients receiving individual psy-
hotherapy for major depression (17.5%; Cooper & Conklin, 2015).
he rates for ERP are also less than that for outpatient CBT for
nipolar depression (24.6%; Hans & Hiller, 2013) and for CBT across
ental disorders (26.2%; Fernandez, Salem, Swift, & Ramtahal,
015). In the larger research context, current findings based on the
1 included RCTs suggest that ERP as a treatment for OCD is not
niquely difficult for clients to complete and any perceived resis-
ance to ERP may  be more anticipated than real. Yet, ERP has faced
n uphill battle to be accepted and utilized by clients and thera-
ists alike. Still, given the small number of studies included in the
resent review, a more comprehensive examination of dropout in
xposure-based therapies is of paramount importance to our field.
f note, the lack of data on refusal opens up the possibility that
ttrition rates for ERP are much higher than our estimated dropout
ates. Inclusion of studies that did not use randomization may  yield
ore accurate estimates of attrition rates in ERP for OCD.
Despite decades of research on ERP for OCD, little is known
bout treatment refusal, mainly because those numbers are less
ommonly reported, and even when reported, not for individual
reatment conditions. Hence, any conclusions regarding the aver-
ge refusal rate for ERP would be premature. We  did find that the
verall refusal rate for treatment of OCD was 12.0%. This is notable
s it is different from what was found for an outpatient anxiety dis-
rders clinic where the pretreatment attrition rate was  30.4% and
he dropout rate was 10.3% (Issakidis & Andrews, 2004). Still, the
ombination of refusal and dropout rates in this study suggests anerror by logit event rate.
approximate attrition rate of 18.7% and 27.0% for ERP and all condi-
tions, respectively. Regardless of whether this number is higher or
lower than expected, as a field we  would like it to be as low as pos-
sible. Thus, future research should continue to examine the impact
of negative beliefs about exposure therapy in relation to attrition
rates as well as to reasons for dropout. With an estimated attrition
rate of 18.7% for one of the most effective treatments for OCD, there
is room for improvement.
Treatment experience, therapist qualification, and number of
sessions were not found to be significant predictors of dropout
from ERP in the present review. Our results are somewhat con-
sistent with previous meta-analyses that examined predictors of
dropout rates. For example, Cooper and Conklin (2015) reported
that therapist credentials did not significantly predict dropout from
individual psychotherapy for major depression. However, treat-
ment duration was a marginally significant predictor of dropout
in their meta-analysis (Cooper & Conklin, 2015). Furthermore, Imel
et al. (2013) found that number of sessions significantly predicted
dropout in treatments for PTSD. The discrepancy between our and
existing findings on the predictive utility of number of sessions
could be due to the limited heterogeneity in ERP dropout rates
as well as the relatively small number of studies included (k = 21),
making it more difficult to detect smaller effects. Indeed, the stan-
dardized regression coefficient of number of sessions in Imel et al.’s
(2013) meta-regression was  0.01. It is unclear if similar results
would be obtained in a larger sample of studies with greater vari-
ability in dropout rate, and our findings must be considered in
the context of the abovementioned limitations. To be explicit, our
results do not indicate that treatment experience, therapist qual-
ification, and number of treatment sessions have no impact on
dropout; rather, they suggest that there is no evidence that they
do.
This review also offers some suggestions to researchers. As a
field, we  need to collect refusal and dropout numbers in all stud-
ies; however, this can be particularly cumbersome during intake.
Alternative procedures should be used to track the actual rate of
enrollment from likely eligible participants. Reasons for refusal
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Franklin, M.  E., & Foa, E. B. (2007). Cognitive behavioral treatment of
obsessive-compulsive disorder. In: P. E. Nathan, & J. M.  Gorman (Eds.), A guide6 C.W. Ong et al. / Journal of A
hould be tracked as they can inform us about perceptions of
reatment. Similarly, care should be taken to confirm enrollment
fter screening for the study. A dropout that occurs prior to treat-
ent assignment may  be coded differently from one that occurs
fter condition assignment. Dropouts that occur after condition
ssignment, but prior to the start of treatment may  also be coded
ifferently from those that occur after many treatment sessions.
uch distinctions are important given that strategies used to retain
articipants may  be contingent on the stage at which participants
rop out of treatment. As such, the point at which dropouts occur
re just as important as participants’ reported reasons for dropping
ut, and both types of data can be used in combination to facili-
ate improvement of treatment acceptability and participant/client
etention. In general, refusal and dropout data are valuable sources
f information, and should be handled like data on other depen-
ent variables in outcome studies. Guidelines for tracking these
ata are described in the Consolidated Standards of Reporting Tri-
ls (CONSORT) statement (e.g., Schulz, Altman, & Moher, 2010). In
ddition, given the inconsistencies and ambiguity in how potential
redictors of dropout were described in the reviewed studies, we
ecommend more detailed reporting of such variables (e.g., level
f supervision, symptom severity of sample) to facilitate coding in
uture meta-analytic research.
There are limitations to consider in interpreting present find-
ngs. This study only examined ERP for OCD. We  did not review
ther types of psychotherapy or pharmacotherapy unless they were
he comparison condition because we were specifically interested
n attrition rates for ERP and how they compared to other treatment
pproaches in RCTs. While comparisons across types of trials might
e interesting, this route was not within the scope of our research
bjectives. Furthermore, the inclusion of treatment dropout and
efusal of other psychotherapeutic and pharmaceutical treatment
odalities were beyond the scope of this review. Notably, individ-
als in medication trials for OCD may  drop out or refuse treatment
ue to side effects or prior medical conditions, complicating direct
omparisons to psychotherapy dropout. Given that participants in
he trials included in this review were aware of the psychotherapy
ondition, dropout across conditions was more comparable.
Another limitation is the exclusion of unpublished papers,
hich might have produced a biased sample of studies. However,
n formulating the boundaries of our inclusion criteria, we elected
o be conservative, and restricted the review to published articles
or two reasons. First, unpublished studies have not undergone the
igorous process of peer review, and could have methodological
eaknesses that compromise the quality of data. Second, until a
tudy has been published, its data can be analyzed in different
ays, leading to final products that potentially diverge from unpub-
ished forms. Furthermore, a visual inspection of the funnel plot
or dropout rates in ERP suggests only slight publication bias (see
ig. 3).
There was also the possibility of incorrectly reported data,
aking it difficult to determine attrition estimates at times.
onetheless, we felt it was important to include all randomized
reatment studies to provide the most complete picture possible.
eporting standards now exist and most researchers are using them
o track participants, resulting in more accurate numbers, which
ay  benefit future meta-analytic efforts. Finally, this study only
ffers information on the rate with which these data are reported
nd the rates of refusal and dropout that can be calculated. The rea-
ons for excluding refusal and dropout rates were not assessed in
his study. Given the interest in attrition for ERP for OCD and the
ffect of assumptions about the high dropout rate of ERP on utiliza-
ion of ERP, having accurate estimates is important. This review may
erve as a benchmark against which to compare the acceptability
f future treatment studies for OCD. Disorders 40 (2016) 8–17
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